These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29569981)

  • 1. Regulatory T-cells within bone marrow-derived stem cells actively confer immunomodulatory and neuroprotective effects against stroke.
    Neal EG; Acosta SA; Kaneko Y; Ji X; Borlongan CV
    J Cereb Blood Flow Metab; 2019 Sep; 39(9):1750-1758. PubMed ID: 29569981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cell is critical for interleukin-33-mediated neuroprotection against stroke.
    Liu X; Hu R; Pei L; Si P; Wang C; Tian X; Wang X; Liu H; Wang B; Xia Z; Xu Y; Song B
    Exp Neurol; 2020 Jun; 328():113233. PubMed ID: 32044328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-Regulatory Cells Confer Increased Myelination and Stem Cell Activity after Stroke-Induced White Matter Injury.
    Zarriello S; Neal EG; Kaneko Y; Borlongan CV
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 31010132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing and dose regimens of marrow mesenchymal stem cell transplantation affect the outcomes and neuroinflammatory response after ischemic stroke.
    Wang LQ; Lin ZZ; Zhang HX; Shao B; Xiao L; Jiang HG; Zhuge QC; Xie LK; Wang B; Su DM; Jin KL
    CNS Neurosci Ther; 2014 Apr; 20(4):317-26. PubMed ID: 24393245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of immuno-tolerance mechanism of the third-party bone marrow-derived mesenchymal stem cells in allogenic transplantation].
    Qi BD; Meng BX; Yang Y; Liu B; Li CC; Xia W; Guo SZ; Zhang C
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):207-12. PubMed ID: 21838003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial intranasal delivery of bone marrow mesenchymal stem cells and insulin-like growth factor-1 improves neurovascularization and functional outcomes following focal cerebral ischemia in mice.
    Shen H; Gu X; Wei ZZ; Wu A; Liu X; Wei L
    Exp Neurol; 2021 Mar; 337():113542. PubMed ID: 33275952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconditioning with Trehalose Protects the Bone Marrow-Derived Mesenchymal Stem Cells Under Oxidative Stress and Enhances the Stem Cell-Based Therapy for Cerebral Ischemic Stroke.
    Shu B; Wan J; Li X; Liu R; Xu C; An Y; Chen J
    Cell Reprogram; 2022 Jun; 24(3):118-131. PubMed ID: 35647904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
    Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
    Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis.
    Wu Y; Ren M; Yang R; Liang X; Ma Y; Tang Y; Huang L; Ye J; Chen K; Wang P; Shen H
    Arthritis Res Ther; 2011 Feb; 13(1):R29. PubMed ID: 21338515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice.
    Chau MJ; Deveau TC; Gu X; Kim YS; Xu Y; Yu SP; Wei L
    BMC Neurosci; 2018 Apr; 19(1):20. PubMed ID: 29649974
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhang H; Xia Y; Ye Q; Yu F; Zhu W; Li P; Wei Z; Yang Y; Shi Y; Thomson AW; Chen J; Hu X
    J Neurosci; 2018 Nov; 38(47):10168-10179. PubMed ID: 30291203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway.
    Chen D; Tang P; Liu L; Wang F; Xing H; Sun L; Jiang Z
    Cell Cycle; 2018; 17(7):858-867. PubMed ID: 29493401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats.
    Wei L; Fraser JL; Lu ZY; Hu X; Yu SP
    Neurobiol Dis; 2012 Jun; 46(3):635-45. PubMed ID: 22426403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor stimulates exosomal microRNA-21 derived from mesenchymal stem cells to ameliorate aGVHD by modulating regulatory T cells.
    Zhu H; Lan L; Zhang Y; Chen Q; Zeng Y; Luo X; Ren J; Chen S; Xiao M; Lin K; Chen M; Li Q; Chen Y; Xu J; Zheng Z; Chen Z; Xie Y; Hu J; Yang T
    FASEB J; 2020 Jun; 34(6):7372-7386. PubMed ID: 32314840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting therapeutic angiogenesis of focal cerebral ischemia using thrombospondin-4 (TSP4) gene-modified bone marrow stromal cells (BMSCs) in a rat model.
    Zhang Q; Zhou M; Wu X; Li Z; Liu B; Gao W; Yue J; Liu T
    J Transl Med; 2019 Apr; 17(1):111. PubMed ID: 30947736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive regulatory T-cell therapy protects against cerebral ischemia.
    Li P; Gan Y; Sun BL; Zhang F; Lu B; Gao Y; Liang W; Thomson AW; Chen J; Hu X
    Ann Neurol; 2013 Sep; 74(3):458-71. PubMed ID: 23674483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2/IL-2R Antibody Complex Enhances Treg-Induced Neuroprotection by Dampening TNF-α Inflammation in an In Vitro Stroke Model.
    Borlongan MC; Kingsbury C; Salazar FE; Toledo ARL; Monroy GR; Sadanandan N; Cozene B; Gonzales-Portillo B; Saft M; Wang ZJ; Moscatello A; Lee JY
    Neuromolecular Med; 2021 Dec; 23(4):540-548. PubMed ID: 33830475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
    Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
    World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia conditioning enhances neuroprotective effects of aged human bone marrow mesenchymal stem cell-derived conditioned medium against cerebral ischemia in vitro.
    Zhang Y; Ma L; Su Y; Su L; Lan X; Wu D; Han S; Li J; Kvederis L; Corey S; Borlongan CV; Ji X
    Brain Res; 2019 Dec; 1725():146432. PubMed ID: 31491422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects and mechanism of interleukin-17-modified mouse bone marrow mesenchymal stem cells on rejection reaction of allogeneic skin transplantation in mice].
    Ma TX; Xu YW; Jiang DY
    Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):234-243. PubMed ID: 32241050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.